For urgent assistance (866) 841-4232,
OR (866) 841-HAEA
Company raises $17,700 for the United States Hereditary Angioedema Association at the American Academy of Allergy, Asthma and Immunology Annual Meeting
BURLINGTON, Mass.–(BUSINESS WIRE)– In honor of the first ever HAE Day upcoming on May 16, 2012, Dyax Corp. (NASDAQ: DYAX), the manufacturer of KALBITOR® (ecallantide) for the treatment of acute attacks of HAE in patients 16 years of age and older, announced a donation of $17,700 to the United States Hereditary Angioedema Association (HAEA), the largest Hereditary Angioedema (HAE) patient group in the world. The donation results from fundraising activities held at the American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting in Orlando, FL, where Dyax dedicated a significant portion of their booth to recognizing HAE Global Awareness Day on May 16, 2012 and raising funds to support the HAEA.
The Dyax booth at AAAAI featured two treadmills on which meeting attendees were invited to walk or run to benefit the HAEA. The company pledged $100 to the HAEA for every mile clocked by meeting attendees, which included clinicians, academicians and allied health professionals, with participants logging nearly 200 miles for the cause. One particularly enthusiastic physician ran ten miles, generating a single donation of $1,000. The fundraiser was the first in a series of events supported by Dyax and will culminate in a donation presented to the HAEA on HAE Day, taking place on May 16, 2012.Read full article